Unknown

Dataset Information

Effect of Flumazenil on Hypoactive Delirium in the ICU: A Double-Blind, Placebo-Controlled Pilot Study.


ABSTRACT: To determine whether the use of flumazenil reverses hypoactive delirium and increases delirium-free days in critically ill patients who were exposed to benzodiazepine therapy during the ICU admission.

Design

This was a single-center, double-blinded, randomized placebo-controlled pilot study.

Setting

Adult ICUs at a large academic medical center in the United States.

Patients

Adult, critically ill patients with benzodiazepine exposure and hypoactive delirium based on the Confusion Assessment Method-ICU and Richmond Agitation Sedation Scale assessments were considered for enrollment.

Interventions

Patients received a test dose of flumazenil starting at 0.1 mg intravenously and titrated up every 5 minutes by 0.1 mg increments up to a maximum total dose of 2 mg. Pat

SUBMITTER: Schomer KJ 

PROVIDER: S-EPMC7098541 | biostudies-literature | 2020 Mar

REPOSITORIES: biostudies-literature